Nluc Reporter Cell Line - RENCA

RENCA, also written RenCa, is an adherent murine renal adenocarcinoma cell line derived from a spontaneous renal cortical tumor in a six-week-old male BALB/c mouse. The cells display epithelial-like morphology and are tumorigenic in mice of the same genetic background. Because RENCA tumors can grow in immunocompetent BALB/c hosts and may disseminate to organs such as the lungs and liver, the parental line has become a widely used syngeneic model for studying renal cancer biology and antitumor immunity. Nluc Reporter Cell Line - RENCA is an engineered derivative expressing NanoLuc luciferase. NanoLuc is a compact 19.1 kDa enzyme that produces bright, ATP-independent luminescence when supplied with a compatible furimazine-based substrate. The resulting signal provides a sensitive means of detecting and quantifying viable reporter-expressing RENCA cells in culture and in appropriately validated animal models.

The reporter line is suitable for investigating renal cancer proliferation, survival, migration, metastatic behavior, and treatment response. In vitro NanoLuc measurements can support multiwell viability and cytotoxicity assays involving small molecules, targeted agents, cytokines, antibodies, immune cells, or combination treatments. Since RENCA cells are compatible with syngeneic BALB/c models, the line is especially useful for examining tumor–immune interactions and evaluating immune checkpoint inhibitors, cytokine-based therapies, adoptive cell approaches, and agents targeting angiogenesis or the tumor microenvironment. Depending on the experimental question, cells may be used in subcutaneous, orthotopic, or experimental metastasis models. Bioluminescence imaging can then assist with longitudinal assessment of primary tumor establishment, renal growth, metastatic dissemination, and therapeutic response in the same animal. Substrate delivery, tissue depth, tumor perfusion, and potential immune recognition of the reporter may influence signal intensity; therefore, reporter stability and the relationship between viable cell number and luminescence should be confirmed in each assay system.